Alzheimers Drugs Market Share and Trends Forecast

The global Alzheimers drugs market reached US$ 7.7 billion. IMARC Group expects the market to reach US$ 12.4 billion by 2032, exhibiting a 5.3% growth rate (CAGR) during 2024-2032. The rising prevalence of Alzheimers disease, advancements in drug development, and increasing public and private funding for neurodegenerative disease research are major factors driving market growth.